Avidity Biosciences (RNA) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: NZ$2.89 M
• Last 3 months FTD volume: NZ$3.59 M
• Last year FTD volume: NZ$3.59 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNA) - since 2020

Avidity Biosciences (RNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
PTC Therapeutics PTCT	NZ$0.48 M	NZ$4.11 M	🇺🇸 USA
Acorda Therapeutics ACOR	N/A	NZ$0.01 M	🇺🇸 USA
Sarepta Therapeutics SRPT	NZ$5.46 M	NZ$38.26 M	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	NZ$0.05 M	NZ$3.61 M	🇺🇸 USA
Fate Therapeutics FATE	NZ$0.12 M	NZ$1.16 M	🇺🇸 USA
Pfizer PFE	NZ$21.73 M	NZ$0.33 B	🇺🇸 USA
GlaxoSmithKline GSK	NZ$94.71 M	NZ$0.14 B	🇬🇧 UK